×

Bode Technology Surpasses Sales Mark of 3.5 Million Buccal DNA Collectors, Expands With New Global And Domestic Territories One of World's Leading and Fastest Growing Forensic DNA Analysis and Services Companies Expands Sales Efforts

NEW YORK, Nov 12, 2010 (BUSINESS WIRE) -- GlobalOptions Group, Inc. (NASDAQ: GLOI), a leading provider of domestic and international risk management services, today announced that Bode Technology, one of the world's largest forensic DNA analysis firms, has surpassed a sales mark of 3.5 million Buccal DNA Collectors in 2010, its greatest sales total ever and another positive sign of Bode's further expansion as a leader in the marketplace. Bolstering the sales of kits was the addition of new territories in the states of Louisiana and Delaware, along with new international sales territories in Hungary and Qatar.

"We are very proud to have reached this milestone in 2010 and are looking forward to further increasing our efforts to assist in the expansion of forensic DNA work around the globe," said Barry Watson, Bode CEO. "The Bode Buccal DNA Collectors are the essential element in kits assisting law enforcement and other agencies in solving violent crime, missing persons and other cold cases, so being able to provide such a large volume to those in the field is a great testament to both the work we are doing and to how fast the market is adopting and implementing new technology." The Buccal DNA Collector is an easy-to-use, reproducible, effective and non-invasive direct cell collection method. Direct collection of samples maximizes the amount of DNA collected and eliminates transfer steps that cause the loss of DNA and the possible chain of custody issues that occur when using collection devices with FTA paper. The collector protects the sample from contamination, allows for the drying of the specimen and easy to archive the final sample after processing. It is the key part of the kit, which contains all components required for documenting, collecting and transporting a DNA sample.

The new sales marks continue to cement Bode's position as a leader in the field of Forensic DNA innovation both across the nation and around the world. In addition to its Cold Case Forensic work like rape and homicide, Bode staff have assisted in missing persons' identification projects for countries that include Bosnia, Mexico, Argentina, Kuwait, Guatemala, Haiti, East Timor, and Peru as well as South Africa, Iraq, Colombia and others. Bode has responded to and assisted in the identification of the missing from mass loss of life incidents, including the World Trade Center, the tsunami in Indonesia, and Hurricane Katrina, as well as both domestic and foreign airline crashes.

Bode Technology Group, Inc.

Bode Technology Group serves the U.S. and international law enforcement and identification markets and is unique in providing both state-of-the-art human DNA analysis and innovative DNA collection products. The range of Bode's services include diverse offerings such as high-throughput DNA testing services, case work analysis, missing person identification, CODIS databanking of convicted offenders or arrestees, private databanking, as well as paternity and non-forensic identification. Our patented DNA collection systems are in use worldwide for collections of DNA from convicted offenders and arrestees, from crime scenes, as well as from parents and children for genealogy and identification services. Our analysts and our research and development teams are constantly looking for better ways to bring previously unused approaches and technologies into the labs for routine use for analysis of challenging samples - be it bones or aged, decayed tissue. On the strength and experience of our research and development teams and casework analysts, Bode is able to offer worldwide DNA analysis services, consulting, training, and validation services on a customized basis. All other information can be found at www.bodetech.com.

GlobalOptions Group, Inc.

GlobalOptions Group (NASDAQ: GLOI) and its subsidiaries provide risk mitigation and management services, including forensic DNA analysis, proprietary DNA collection products, and related research services to law enforcement agencies, federal and state governments, crime laboratories and disaster management organizations. Additional information regarding GlobalOptions Group is available at our website at www.globaloptionsgroup.com.

Statements in this press release regarding the company's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. The company wishes to caution readers not to place undue reliance on such forward-looking statements, which statements are made pursuant to the Private Securities Litigation Reform Act of 1994, and as such, speak only as of the date made. To the extent the content of this press release includes forward-looking statements, they involve various risks and uncertainties including the successful integration of the acquired businesses, projected financial information, and the continued successful implementation of the company's business strategy.

Certain of these risks and uncertainties will be described in greater detail in GlobalOptions Group's filings with the Securities and Exchange Commission.

GlobalOptions Group is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a as a result of new information, future events or otherwise.

SOURCE: GlobalOptions Group, Inc.

CONTACT: IR: Lippert/Heilshorn & Assoc. Jody Burfening, 212-838-3777 jburfening@lhai.com Copyright Business Wire 2010 -0- KEYWORD: United States

North America

New York INDUSTRY KEYWORD: Public Policy/Government

Law Enforcement/Emergency Services

Professional Services

Banking

Finance SUBJECT CODE: Product/Service